Clinical Trial Update: A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea

View source ↗

Summary

A post-marketing surveillance study of niraparib in adults with approved indications in South Korea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Neoplasms

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Takeda | Conditions: Ovarian Neoplasms | Status: COMPLETED